Skip to main content
. 2024 Apr 30;9(5):103443. doi: 10.1016/j.esmoop.2024.103443

Figure 2.

Figure 2

Figure 2

Disease-free survival. (A) Disease-free survival in high-risk patients included in the UNIRAD trial, according to treatment arms. (B) Disease-free survival according to EPclin low- and high-risk subgroups. (C) Disease-free survival according to quartiles of the EPclin score.

CI, confidence interval; EVE, everolimus; HR, hazard ratio; iDFS, invasive disease-free survival; KM, Kaplan–Meier.